For example, targeting the overexpressed CD123 marker on CD34+ CD38– leukemic stem cells in acute myelogenous leukemia impairs leukemic stem cells homing to the bone marrow and induces a decrease in the overall AML cell repopulation (Jin et al., 2009). This evidence concerns the gene CD34 and acute myeloid leukemia.